COMPANY

Tolerance Bio

Profile checked Oct 10, 2026

Funding and NIH signals

SEC Form D raise Raised $15.1M (Form D filed Jun 18, 2026). SEC Form D 0001493152-26-029282 (Jun 18, 2026)
Evidence (1 event)
- Jun 18, 2026 · SEC Form D 0001493152-26-029282
  Name of Issuer: Tolerance Bio Inc.; CIK: 2075488; Address: Philadelphia, PA; Submission type: D; Filing date: 2026-06-18; Industry Group: Biotechnology; Date of First Sale: 2026-06-03; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: Indefinite; Total Amount Sold: 15101584; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals

Sep 28, 2026 Partnership Partnership / licensing announced Sep 28, 2026. Source: company's own press page. source ↗
Sep 8, 2025 Partnership Partnership / licensing announced Sep 8, 2025. Source: company's own press page. source ↗
Dec 19, 2024 Raise Private equity round — Seed: $20.2M (total, as published), announced Dec 19, 2024. Source: company's own press page. source ↗
Oct 15, 2024 Raise Private equity round — Seed: $17.2M (total, as published), announced Oct 15, 2024. Source: company's own press page. source ↗

Raised: $37.4M. Last 2 years.

Dec 19, 2024 Private equity round — Seed: $20.2M (total, as published), announced Dec 19, 2024. Source: company's own press page. source ↗
Oct 15, 2024 Private equity round — Seed: $17.2M (total, as published), announced Oct 15, 2024. Source: company's own press page. source ↗
Sep 28, 2026 Partnership / licensing announced Sep 28, 2026. Source: company's own press page. source ↗
Sep 8, 2025 Partnership / licensing announced Sep 8, 2025. Source: company's own press page. source ↗